BEAM CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION AS FRONT-LINE THERAPY OF HIGH-RISK PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA AND UNFAVORABLE CLINICAL PRESENTATION
S. Cortelazzo et al., BEAM CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION AS FRONT-LINE THERAPY OF HIGH-RISK PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA AND UNFAVORABLE CLINICAL PRESENTATION, Blood, 90(10), 1997, pp. 498-498